A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2001
11/07/2001	EP1150950A2 Anthranilic acid derivatives
11/07/2001	EP1150711A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence
11/07/2001	EP1150709A2 Anti-microbial agents, diagnostic reagents, and vaccines based on apicomplexan parasite components
11/07/2001	EP1150708A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
11/07/2001	EP1150707A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS
11/07/2001	EP1150706A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response
11/07/2001	EP1150704A1 New use of melagatran
11/07/2001	EP1150697A1 High molecular weight extracts of convolvulus arvensis (field bindweed)
11/07/2001	EP1150694A1 Cell composition containing macrophages, presenting anti-infectious and hematopoietic properties, and a process for preparing the same
11/07/2001	EP1150693A1 Immunogenic compositions for use as vaccines
11/07/2001	EP1150691A2 Novel antisense inhibition of rad51
11/07/2001	EP1150690A1 Chemical compounds
11/07/2001	EP1150689A1 Chemical compounds
11/07/2001	EP1150666A1 Stimulating neutrophil function to treat inflammatory bowel disease
11/07/2001	EP1150658A2 Method for controlling liposome size
11/07/2001	EP1150570A1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone
11/07/2001	EP0879223B1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions
11/07/2001	EP0758452B1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same
11/07/2001	EP0726772B1 A method for sensitization of cancer cells for killer cell mediated lysis
11/07/2001	EP0702560B1 Immunologic enhancement with intermittent interleukin-2 therapy
11/07/2001	EP0689596B1 Stimulation of immune response by viral protein
11/07/2001	EP0655996B1 Substituted benzylamino nitrogen containing non-aromatic heterocycles
11/07/2001	CN1321190A i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene
11/07/2001	CN1321167A Method for detecting and purifying CD8+T lymphocyte populations, specific of peptides present in context of HLA
11/07/2001	CN1321151A Chemical compounds
11/07/2001	CN1321150A Amide derivs. useful as inhibitors of production of cytokines
11/07/2001	CN1321086A Mucosal originated drug delivery system and animal applications
11/07/2001	CN1320617A Polypeptide-human Pax protein 14 and polynucleotide for coding it
11/07/2001	CN1320615A Polypeptide-human Pax protein 16 and polynucleotide for coding it
11/07/2001	CN1320614A Polypeptide-human translation initiation factor accessory factor 81 and polynucleotide for coding it
11/07/2001	CN1320613A Polypeptide-human ribosome S7 protein 14 and polynucleotide for coding it
11/07/2001	CN1320610A Polypeptide-G-beta similar protein 29 and polynucleotide for coding it
11/07/2001	CN1320438A Process for preparing medicines
11/07/2001	CN1320427A Composite melatonin and its preparing process
11/07/2001	CN1074411C Method for preparing medicinal composition in noval physical form contg. heterocyclic amide deriv.
11/07/2001	CN1074289C Oral liquor having functions of inhibiting tumor and regulating immunization
11/06/2001	US6313312 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy
11/06/2001	US6313298 Spiro-indolines as Y5 receptor antagonists
11/06/2001	US6313269 Tumor necrosis factor related receptor, TR6
11/06/2001	US6313264 Effector proteins of Rapamycin
11/06/2001	US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
11/06/2001	US6313129 Therapeutic compounds
11/06/2001	US6313117 Succinate derivative compounds useful as cysteine protease inhibitors
11/06/2001	US6313116 Phosphodiesterase inhibitors
11/06/2001	US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
11/06/2001	US6312907 An isolated nucleic acid encoding a gene for decorin binding protein from borrelia; diagnosis and therapy of lyme disease in humans and animals
11/06/2001	US6312899 A polynucleotide probe for the detection and diagnositic staging of lymphocyte differentiation
11/06/2001	US6312753 Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses
11/06/2001	US6312711 Vehicles for food and drugs, stress proteins, sequential epitopes of antigen structure
11/06/2001	US6312703 Drugs or cosmetics, liquid crystal solids and lecithin
11/06/2001	US6312700 Fusion proteins and receptors
11/06/2001	US6312693 Antibodies against human CD40
11/06/2001	US6312692 Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells
11/06/2001	US6312689 Antibodies or antigens
11/06/2001	US6312686 Modulating the permeability of a physiological barrier with an agent that modulates tyrosine phosphorylation
11/03/2001	CA2345760A1 Pharmaceutical uses for fluoroalkoxybenzylamino and alkoxybenzylamino derivatives of nitrogen containing heterocycles
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081574A2 Regulation of nf-at interacting protein nip 45 variant
11/01/2001	WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	WO2001081554A1 Pneumovirus ns proteins antagonising the interferon (ifn) response
11/01/2001	WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/01/2001	WO2001081399A1 A novel polypeptide, a human pax protein 14 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081398A1 A novel polypeptide, a human pax protein 16 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081397A1 A novel polypeptide, a translation initiation factor human cofactor 81 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081396A1 A new polypeptide - human ribosomal s7 protein 14 and the polynucleotide encoding it
11/01/2001	WO2001081391A1 A novel polypeptide, a protein 29 similar to g beta and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081363A1 Novel compounds
11/01/2001	WO2001081348A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO[3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS
11/01/2001	WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
11/01/2001	WO2001081340A2 Heterocycles that are inhibitors of impdh enzyme
11/01/2001	WO2001081337A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001081323A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/01/2001	WO2001081316A2 Substituted phenyl farnesyltransferase inhibitors
11/01/2001	WO2001081311A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
11/01/2001	WO2001081304A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001081298A2 Cyclic carboxylic acids as integrin antagonists
11/01/2001	WO2001080887A2 Methods and chemokin compositions for inducing an immune response
11/01/2001	WO2001080883A1 Bispecific molecules and uses thereof
11/01/2001	WO2001080882A2 Methods and compositions for eliciting an immune response
11/01/2001	WO2001080880A2 Apoptotic agents
11/01/2001	WO2001080864A2 Chemical modification of mammalian urine and blood
11/01/2001	WO2001080836A1 Use of particulate vectors in immunomodulation
11/01/2001	WO2001080807A2 Medicine containing polysaccharide substances for activating apoptosis
11/01/2001	WO2001060381B1 Nucleoside analogs with carboxamidine-modified bicyclic base
11/01/2001	WO2001041762A3 Valdecoxib compositions
11/01/2001	WO2001041761A3 Valdecoxib compositions
11/01/2001	WO2001036641A3 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO
11/01/2001	WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001	WO2001032866A3 Hybrid adaptor receptors
11/01/2001	WO2001029049A3 Imidazole derivatives as phosphodiesterase vii inhibitors
11/01/2001	WO2001021620A3 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines
11/01/2001	WO2001014318A3 New effectors of dipeptidyl peptidase iv for topical use
11/01/2001	WO2000066111A9 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/01/2001	WO2000032632A9 Allo- and auto-reactive t-cell epitopes from rhesus protein and their use
11/01/2001	US20010036946 Antiinflammatory agents
11/01/2001	US20010036923 Complex
11/01/2001	US20010036921 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/01/2001	US20010036919 Preventing airway mucus production by administration of EGF-R antagonists
11/01/2001	US20010036655 Vaccine

1 ... 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 ... 1172